AT386544T - Photodynamic therapy for treatment of hair loss - Google Patents

Photodynamic therapy for treatment of hair loss

Info

Publication number
AT386544T
AT386544T AT02774200T AT02774200T AT386544T AT 386544 T AT386544 T AT 386544T AT 02774200 T AT02774200 T AT 02774200T AT 02774200 T AT02774200 T AT 02774200T AT 386544 T AT386544 T AT 386544T
Authority
AT
Austria
Prior art keywords
treatment
hair loss
photodynamic therapy
photodynamic
therapy
Prior art date
Application number
AT02774200T
Other languages
German (de)
Inventor
Guillermo Simkin
Anna Richter
David Hunt
John North
Peter Lutwyche
Ronald Boch
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US33829501P priority Critical
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of AT386544T publication Critical patent/AT386544T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0616Skin treatment other than tanning
    • A61N5/0617Hair treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42Colour properties
    • A61K2800/43Pigments; Dyes
    • A61K2800/434Luminescent, Fluorescent; Optical brighteners; Photosensitizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81Preparation or application process involves irradiation
AT02774200T 2001-11-09 2002-11-08 Photodynamic therapy for treatment of hair loss AT386544T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US33829501P true 2001-11-09 2001-11-09

Publications (1)

Publication Number Publication Date
AT386544T true AT386544T (en) 2008-03-15

Family

ID=23324214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02774200T AT386544T (en) 2001-11-09 2002-11-08 Photodynamic therapy for treatment of hair loss

Country Status (11)

Country Link
US (2) US20050090481A1 (en)
EP (2) EP1443964B1 (en)
JP (3) JP2005514346A (en)
AT (1) AT386544T (en)
AU (2) AU2002340676B2 (en)
BR (2) BR0214004A (en)
CA (2) CA2466425A1 (en)
DE (1) DE60225169D1 (en)
NZ (2) NZ533036A (en)
WO (2) WO2003039596A1 (en)
ZA (2) ZA200404486B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303578B2 (en) * 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
US7264629B2 (en) * 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
AT386544T (en) * 2001-11-09 2008-03-15 Quadra Logic Tech Inc Photodynamic therapy for treatment of hair loss
US7534255B1 (en) 2003-01-24 2009-05-19 Photothera, Inc Low level light therapy for enhancement of neurologic function
US20060265028A1 (en) * 2003-04-23 2006-11-23 Qlt Inc. Hair growth
CA2525569A1 (en) * 2003-05-24 2004-12-09 Ledeep, Llc Skin tanning and light therapy system and method
EP1735054A4 (en) * 2004-03-09 2010-01-20 Ledeep Llc Phototherapy systems and methods
CA2457214A1 (en) 2004-02-06 2005-08-06 Morgan Chun Lam Photodynamic therapy for the treatment of acne
ES2400566T3 (en) 2004-06-09 2013-04-10 Qlt, Inc. Photodynamic therapy for the treatment of overactive sebaceous glands disorders using verteporfin and / or topically applied lemuteporfin
AU2011256899B2 (en) * 2004-02-06 2014-08-21 Valeant Pharmaceuticals International, Inc. Photodynamic therapy for the treatment of acne
US7825153B2 (en) 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
JP4685441B2 (en) * 2004-12-28 2011-05-18 ビタミンC60バイオリサーチ株式会社 Hair restorer composition and hair growth enhancers
US20060161226A1 (en) * 2005-01-18 2006-07-20 Mcmickle George R Apparatus and method for reducing follicular cell apoptosis
JP4911569B2 (en) * 2006-01-18 2012-04-04 ローム株式会社 Multilayer waveguide and a manufacturing method thereof
US7575589B2 (en) 2006-01-30 2009-08-18 Photothera, Inc. Light-emitting device and method for providing phototherapy to the brain
WO2007109136A2 (en) * 2006-03-17 2007-09-27 Light Dimensions, Inc. Light-based enhancing apparatuses and methods of use
US8308784B2 (en) 2006-08-24 2012-11-13 Jackson Streeter Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
US7922688B2 (en) 2007-01-08 2011-04-12 Restoration Robotics, Inc. Automated delivery of a therapeutic or cosmetic substance to cutaneous, subcutaneous and intramuscular tissue regions
JP2008246144A (en) * 2007-03-30 2008-10-16 Matsushita Electric Works Ltd Method and system for hair growth control
EP2005942A1 (en) * 2007-06-11 2008-12-24 GIULIANI S.p.A. Cosmetic composition for treatment of canities
DK2214643T3 (en) * 2007-11-02 2014-05-26 Acrux Dds Pty Ltd A transdermal delivery system for hormones and steroids
FR2924021B1 (en) * 2007-11-27 2010-08-13 Du Vernet Michele Eymard Composition for skin treatment by photodynamic therapy
US20090254154A1 (en) * 2008-03-18 2009-10-08 Luis De Taboada Method and apparatus for irradiating a surface with pulsed light
US7848035B2 (en) * 2008-09-18 2010-12-07 Photothera, Inc. Single-use lens assembly
US20100211136A1 (en) * 2009-02-19 2010-08-19 Photothera, Inc. Apparatus and method for irradiating a surface with light
US20120101427A1 (en) * 2009-04-28 2012-04-26 Gerard Farmer Novel photosensitizer formulations for oral administration
BRPI1011316A2 (en) 2009-05-26 2016-03-15 Gen Hospital Corp apparatus and method for delivering a substance to the skin tissue method for treating a subject having a skin condition and kit
US20110124736A1 (en) * 2009-11-09 2011-05-26 Allergan, Inc. Compositions and methods for stimulating hair growth
JP5739679B2 (en) * 2010-03-01 2015-06-24 ロート製薬株式会社 External composition
EP2616144A4 (en) * 2010-09-16 2014-03-19 Univ Case Western Reserve Photodynamic therapy system, device and associated method of treatment
US20130289089A1 (en) 2011-01-13 2013-10-31 Jerome A. Morris Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses Thereof
RU2014126871A (en) 2011-12-02 2016-02-10 Колгейт-Палмолив Компани Compositions for oral hygiene
CN104703624A (en) * 2012-07-11 2015-06-10 德米拉股份有限公司 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
ES2469240B1 (en) * 2012-11-14 2015-04-20 Universidad Autonoma De Madrid Use of a photosensitizing agent capable of producing reactive oxygen species in the preparation of a medicament useful for photodynamic therapy of a related disease stem cell, using "in vitro" and pharmaceutical composition.
GB201221125D0 (en) 2012-11-23 2013-01-09 Morex Dev Partners Llp Pharmaceutial formulations
JP6185372B2 (en) * 2013-11-21 2017-08-23 ポーラ化成工業株式会社 External preparation for skin

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR693906A (en) * 1930-04-14 1930-11-26 Improvements to squelch combustion engines
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
WO1988005653A1 (en) * 1987-01-28 1988-08-11 Proctor Peter H Topical composition for stimulating hair growth with stable free radicals
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US5871480A (en) 1991-10-29 1999-02-16 Thermolase Corporation Hair removal using photosensitizer and laser
FR2693906B1 (en) 1992-07-21 1994-10-07 Vichy Cie Fermiere Etabl Therm Crude extracts of blue algae, processes for their preparation and their applications in cosmetology and dermatology.
JPH08505361A (en) * 1992-08-17 1996-06-11 クアドラ・ロジック・テクノロジーズ・インコーポレーテッド Method of inhibiting broken or their growth undesirable cell or tissue
US5965530A (en) * 1993-03-26 1999-10-12 Amgen Inc. Therapeutic uses of keratinocyte growth factor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
EP0741572A1 (en) * 1994-01-27 1996-11-13 Schering Aktiengesellschaft AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14$g(a),17$g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17$g(b)-DIOL
US5669916A (en) 1994-09-28 1997-09-23 The General Hospital Corporation Method of hair removal
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US5703230A (en) * 1994-12-02 1997-12-30 University Of British Columbia Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
US6162211A (en) * 1996-12-05 2000-12-19 Thermolase Corporation Skin enhancement using laser light
US5880145A (en) * 1997-05-07 1999-03-09 The University Of British Columbia Class of benzoporphyrin derivative photoactive compounds
AT253068T (en) * 1997-05-07 2003-11-15 Univ British Columbia A class photo of effective benzoporphyrin derivatives connections
IL132066A (en) 1997-05-07 2008-06-05 Quadra Logic Tech Inc Bis(ethylene glycol) tetraalkyl esters of monohydrobenzoporphyrin derivatives as photoactive agents
WO1999059556A1 (en) * 1998-05-15 1999-11-25 Nasa/Johnson Space Center Externally triggered microcapsules
US6676655B2 (en) * 1998-11-30 2004-01-13 Light Bioscience L.L.C. Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
US6283956B1 (en) * 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
CA2369542C (en) 1999-04-23 2009-10-27 Qlt Inc. Immuno-adjuvant pdt treatment of metastatic tumors
DE60032908T2 (en) 1999-08-02 2007-06-28 The Regents Of The University Of Michigan, Ann Arbor Targeted fiberless radiative effectors
US6607522B1 (en) * 2000-03-16 2003-08-19 General Hospital Corporation Methods for tissue welding using laser-activated protein solders
WO2001072957A2 (en) * 2000-03-31 2001-10-04 Nobuyuki Itoh Fibroblast growth factor-like molecules and uses thereof
GB2361430A (en) * 2000-04-17 2001-10-24 Photo Therapeutics Ltd Therapeutic discharge lamps
CA2408332C (en) 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
US6693093B2 (en) * 2000-05-08 2004-02-17 The University Of British Columbia (Ubc) Drug delivery systems for photodynamic therapy
GB0019055D0 (en) * 2000-08-03 2000-09-27 Unilever Plc Antiperspirant and deodorant products and methods for their use
US20040033493A1 (en) * 2001-01-31 2004-02-19 Tchernev Velizar T. Proteins and nucleic acids encoding same
MXPA04003821A (en) * 2001-11-02 2004-07-30 Procter & Gamble Composition containing a cationic polymer and water insoluble solid material.
AT386544T (en) * 2001-11-09 2008-03-15 Quadra Logic Tech Inc Photodynamic therapy for treatment of hair loss
CA2482038A1 (en) * 2002-04-22 2003-10-30 The Procter & Gamble Company Shampoo containing a cationic guar derivative

Also Published As

Publication number Publication date
ZA200404486B (en) 2005-09-27
EP1443964A1 (en) 2004-08-11
WO2003039597A1 (en) 2003-05-15
BR0214009A (en) 2004-11-03
EP1441767A1 (en) 2004-08-04
CA2466437C (en) 2012-10-30
EP1443964B1 (en) 2008-02-20
CA2466425A1 (en) 2003-05-15
WO2003039596A1 (en) 2003-05-15
AU2002340659B2 (en) 2008-04-10
JP2005513001A (en) 2005-05-12
WO2003039596B1 (en) 2003-09-12
DE60225169D1 (en) 2008-04-03
US20040015214A1 (en) 2004-01-22
CA2466437A1 (en) 2003-05-15
AU2002340676B2 (en) 2008-12-11
JP2005514346A (en) 2005-05-19
JP2010077164A (en) 2010-04-08
NZ533036A (en) 2006-04-28
US7090691B2 (en) 2006-08-15
US20050090481A1 (en) 2005-04-28
BR0214004A (en) 2004-11-03
NZ533037A (en) 2006-06-30
ZA200404480B (en) 2006-03-29

Similar Documents

Publication Publication Date Title
DE60105295D1 (en) Quinazoline derivatives for the treatment of tumors
DK1267866T3 (en) Treatment of respiratory diseases
DE60019556D1 (en) 2-amino-benzoxazinonderivate for treatment of obesity
DE60024638D1 (en) Method for treatment of skin by electrostatic spray
DE60143801D1 (en) Treatment of obesity
DE60219793D1 (en) Method for treatment of cytokine mediated diseases
AT539701T (en) Composite sling for treatment of incontinence
DE60028003D1 (en) Bifidobacterium for treatment of inflammatory diseases
DE50108380D1 (en) Skin treatment agents
AT361117T (en) Device for treatment of heart failure
DE60138129D1 (en) Apparatus for treatment of teeth
DE60028960D1 (en) Hyperthermia treatment of hepatitis c
DE69918087D1 (en) Topical formulations for treatment of nail fungal diseases
AT512163T (en) Administration of agents for the treatment of inflammation
DE60117043D1 (en) Treatment of mucositis
DE602004019907D1 (en) Device for treatment of tissue
DE60036490D1 (en) Composition for treatment of prostate cancer
DE60133029D1 (en) Means for prevention or treatment of psoriasi
DE60045751D1 (en) Therapeutic treatment androgenrezeptorbedingter suffering
AT541860T (en) Human tumors antibody against CD40 for the treatment of b-cell
DE60328898D1 (en) Comprehensive treatment of vertigo
DE69802094D1 (en) Device for therapeutic treatment of wounds
DE69939651D1 (en) Treatment of hyperproliferative diseases
DE60126980D1 (en) agents and therapeutic methods of their use for treatment of amyloidogenic disease
DE69723476D1 (en) Means for treatment of hair

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties